3FEMIA RA,GOYETTE RE. The science of megestrol acetate delivery:potential to improve outcomes in cachexia [J]. Biodrugs, 2005,19(3) :179 - 187.
4PASCUAL LOPEZ A, ROQUE 1 FIGULS M, URRUTIA CUCHI G, et al. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome [ J ]. J Pain Symptom Manage,2004,27(4) :360 - 369.
5GAVER RC,MOVAHHED HS,FARMEN RH,et al. Liquid chromatographic procedure for the quantitative analysis of megestrol acetate in human plasma [ J ]. J Pharrn Sci, 1985,74 ( 6 ) : 664 - 667.
6MATIN K,EGORIN MJ,BALLESTEROS MF,et al. Phase Ⅱ and pharmacokinetic study of vinblastine and high-dose megestrol acetate [ J ]. Cancer Chemother Pharmcol, 2002,50 ( 3 ) : 179 - 185.
7ALAKHOV V, PIETRZYNSKI G, PATEL K, et al. Pluronic block copolymers and pluronic poly( acrylic acid) rnicrogels in oral delivery of megestrol acetate [J]. J Pharm Pharmacol, 2004,56 (10) :1233 - 1241.
8MILLER AA, BECHER R,SCHMIDT CG. Plasma-concentrations of medroxyprogesterone acetate and megesterot acetate during long-term follow-up in patients treated for mctastatic breast-cancer [J]. J Cancer Res Clin onco1,1988,114(2):186-190.
9LOHMUS M,KENDER T. Determination of gestagens in kidney fat by liquid chromatography tandem mass spectrometry[J]. Anal Chim Acta,2007,586(1 -2):233-238.
10ADLERCREUTZ H, ERIKSEN PB, CHRISTENSEN MS. Plasma concentrations of megestrol acetate and medroxyprogesterone acetate after single oral administration to healthy subjects [ J ]. J Pharm Biomed Anal, 1983,1 ( 2 ) : 153 - 162.
